Health Status, Quality of Life, Psychosocial Well-being, and Wearables Data of Patients With Active Ulcerative Colitis Receiving Filgotinib Therapy (FilgoColitis Study): Protocol for a Real-world Observational Study

BACKGROUND: Filgotinib was approved in Germany for treating patients with moderate to severe active ulcerative colitis in November 2021. It represents a preferential Janus kinase 1 inhibitor. The FilgoColitis study began recruiting immediately after approval and aims to assess filgotinib effectivene...

Descripción completa

Detalles Bibliográficos
Autores principales: Plachta-Danielzik, Sandra, Grasskemper, Lena, Schmidt, Karen, Schreiber, Stefan, Bokemeyer, Bernd
Formato: Online Artículo Texto
Lenguaje:English
Publicado: JMIR Publications 2023
Materias:
Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10203929/
https://www.ncbi.nlm.nih.gov/pubmed/37155235
http://dx.doi.org/10.2196/42574

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10203929/
https://www.ncbi.nlm.nih.gov/pubmed/37155235
http://dx.doi.org/10.2196/42574

Ejemplares similares